AXSM today
$141.38-$2.99 (-2.07%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourAscending Triangle
1 hourStrong Bearish
15 minBullish
5 minBullish
Daily trend turns up above $169.96
Key levels
Resistance$155.18
Resistance$144.13
Support$136.00
Support$123.00
Latest news & SEC filings
AnalystMorgan Stanley keeps Equal-Weight on Axsome Therapeutics, cuts target to $223
AnalystMizuho keeps Outperform rating on Axsome Therapeutics, cuts price target to $272
All AXSM news →About Axsome Therapeutics
Axsome Therapeutics is a biopharmaceutical company that develops and sells medicines for disorders of the brain and nervous system. Its approved products treat major depressive disorder, excessive daytime sleepiness tied to narcolepsy or obstructive sleep apnea, and acute migraine in adults. The company also runs clinical programs for agitation in Alzheimer's disease, ADHD, binge eating disorder, narcolepsy, fibromyalgia, and other brain-related illnesses. It sells mainly in the United States, with some products available in Europe and parts of the Middle East and North Africa through partners.
Based on the company's 10-K filed Feb 23, 2026.
Nasdaq · Healthcare
Axsome Therapeutics, Inc. (AXSM)
What Is the Price Target for AXSM?
SEPT Low Target
$238.00
SEPT Mid Target
$275.00
SEPT High Target
$316.00
Analyst Consensus
$275.00
Is AXSM a Buy or Sell Right Now?
Thesis
- •Revenue growing 65.5% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AXSM.
Start Free Trial →Is AXSM Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$207.26
15
Moat Score
NONE
4/9
Piotroski Score
5.0
Altman Z-Score
What Is Smart Money Doing with AXSM?
Insider Signal
SELLING
0 buys / 14 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| TABUTEAU HERRIOT | director officer 10% owner | Buy | 4,660 | $23K | Aug 6, 2026 |
| TABUTEAU HERRIOT | director officer 10% owner | Sale | 4,660 | $997K | Aug 6, 2026 |
| TABUTEAU HERRIOT | director officer 10% owner | Buy | 45,004 | $223K | Aug 5, 2026 |
| TABUTEAU HERRIOT | director officer 10% owner | Sale | 45,004 | $9.5M | Aug 5, 2026 |
| JEFFS ROGER | director | Sale | 286 | $71K | Jun 11, 2026 |
| Mahony Susan | director | Sale | 300 | $74K | Jun 10, 2026 |
| Coleman Mark | director | Sale | 643 | $160K | Jun 10, 2026 |
| JEFFS ROGER | director | Sale | 286 | $70K | Jun 10, 2026 |
| TABUTEAU HERRIOT | director officer 10% owner | Buy | 49,670 | $246K | Jun 9, 2026 |
| TABUTEAU HERRIOT | director officer 10% owner | Sale | 49,670 | $12.0M | Jun 9, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →AXSM Growth Story
Revenue YoY
65.5%
3yr Revenue CAGR
N/A%
EPS Growth YoY
38.56%
FCF Growth YoY
27.0%
Revenue Trend
ACCELERATING
Dark Pool Trades for AXSM
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for AXSM, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:40:54 | $140.47 | 61,900 | $$8.7M | BUY |
| 18:28:35 | $139.92 | 1,200 | $$168K | SELL |
| 18:28:08 | $139.53 | 100,000 | $$14.0M | SELL |
| 17:58:17 | $139.72 | 2,029 | $$283K | BUY |
| 17:58:14 | $139.71 | 2,300 | $$321K | BUY |
5 dark pool trades shown · $$23.4M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for AXSM
PREVIEWSEPT Investing provides real-time options flow tracking for AXSM, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $175 | Mar 19 | 126 | $$3000 | 4 | SWEEP |
| CALL | $130 | Nov 20 | 7 | $$4160 | 4 | SWEEP |
2 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Axsome Therapeutics, Inc. (AXSM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →AXSM — frequently asked questions
What is AXSM stock price today?
Axsome Therapeutics, Inc. (AXSM) is at $141.38, down 2.07% (-$2.99) at the Nov 13, 2026 close.
Why is AXSM stock moving today?
Latest AXSM news — Nov 13, 2026: Morgan Stanley keeps Equal-Weight on Axsome Therapeutics, cuts target to $223 · Nov 4, 2026: Mizuho keeps Outperform rating on Axsome Therapeutics, cuts price target to $272
What is the AXSM price target?
The average analyst price target for AXSM is $275.00, ranging from $238 to $316, based on 15 analysts. Latest: Piper Sandler maintains on Oct 26, 2026.
What do analysts rate AXSM?
Analyst ratings for AXSM: 0 Buy, 29 Hold, 0 Sell — consensus Hold.
Did AXSM beat earnings?
AXSM last reported on Aug 10, 2026: EPS -$0.99.
Does AXSM pay a dividend?
AXSM does not currently pay a dividend.
What are AXSM support and resistance levels?
Support: $136.00, $123.00, $114.91. Resistance: $144.13, $155.18, $169.96.
What are insiders doing with AXSM?
Insider activity: SELLING, 0 buys and 14 sells in the last 90 days.
What is the latest news on AXSM?
Nov 13, 2026: Morgan Stanley keeps Equal-Weight on Axsome Therapeutics, cuts target to $223 · Nov 4, 2026: Mizuho keeps Outperform rating on Axsome Therapeutics, cuts price target to $272